Press Release ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival vs. THP as 1st-line therapy for patients with HER2+ metastatic breast cancer 21 April 2025
Press Release CI Global Asset Management Announces Risk Rating Change for CI U.S. Minimum Downside Volatility Index ETF (CUDV.B) 21 April 2025
Press Release BJ’s Wholesale Club Announces First Quarter Fiscal 2025 Earnings Conference Call Date 21 April 2025
Press Release AIA Group Digital Transformation Strategy Profile 2025 – Accelerators, Incubators and Innovation Programs – ResearchAndMarkets.com 21 April 2025
Press Release Income Lab: Retirement Planning Just Got Faster and Easier for Advisors Who Custody With Schwab Advisor Services™ 21 April 2025
Press Release Lattice Semiconductor Schedules First Quarter 2025 Results Conference Call 21 April 2025
